False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies

Haemophilia

Volumn 18, Issue 5, 2012, Pages 777-781

  Sahud, M ^a   Zhukov, O ^a   Mo, K ^a   Popov, J ^a   Dlott, J ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

FVIII antibodies; FVIII ELISA; Lupus anticoagulants; Neutralizing inhibitors; Phospholipid antibodies

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 9;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROTHROMBIN TIME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, NEUTRALIZING; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; FALSE POSITIVE REACTIONS; HEMOPHILIA A; HUMANS; IMMUNOGLOBULIN G; LUPUS COAGULATION INHIBITOR; MALE;

EID: 84865548208     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02781.x     Document Type: Article

References (32)

1. Saxena R, Dhot PS, Saraya AK, Singh H, Malhotra OP. Simultaneous occurrence of factor VIIIC inhibitor and lupus anticoagulant. Am J Hematol 1993; 42: 232-3.
2. Nuss R, Jacobson L, Hathaway WE, Manco-Johnson M. Evidence for antiphospholipid antibodies in hemophilic children with factor VIII inhibitors. Recombinate PUP Study Group. Thromb Haemost 1999; 82: 1559-60.
3. Biron C, Durand L, Lemkecher T et al. Simultaneous occurrence of lupus anticoagulant, factor VIII inhibitor and localized pemphigoid. Am J Hematol 1996; 51: 250-1.
4. Sahud MA, Pratt KP, Zhukov O, Qu K, Thompson AR. ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia 2007; 13: 317-22.
5. Hoyer LW. Hemophilia A. N Engl J Med 1994; 330: 38-47.
6. Gouw SC, van der Bom JG, Marijke vdB. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood 2007; 109: 4648-54.
7. Verbruggen B. Diagnosis and quantification of factor VIII inhibitors. Haemophilia 2010; 16: 20-4.
8. Sahud MA. Factor VIII inhibitors. Laboratory diagnosis of inhibitors. Semin Thromb Hemost 2000; 26: 195-203.
9. Shetty S, Ghosh K, Mohanty D. An ELISA assay for the detection of factor VIII antibodies - comparison with the conventional Bethesda assay in a large cohort of haemophilia samples. Acta Haematol 2003; 109: 18-22.
10. Martin PG, Sukhu K, Chambers E, Giangrande PL. Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs. Clin Lab Haematol 1999; 21: 125-8.
11. Tripodi A, Mancuso ME, Chantarangkul V et al. Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants. Clin Chem 2005; 51: 1883-5.
12. Penmetsa GK, Rodgers GM, Smock KJ. Avoiding errors in the laboratory evaluation of potent lupus anticoagulants. Am J Hematol 2010; 85: 272-4.
13. Green D. Interpreting coagulation assays. Blood Coagul Fibrinolysis 2010; 21(Suppl 1): S3-6.
14. Favaloro EJ, Bonar R, Duncan E et al. Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation. Pathology 2007; 39: 504-11.
15. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
16. Kasper CK, Aledort L, Aronson D et al. Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 612.
17. Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995; 73: 247-51.
18. Takamiya O, Kinoshita S. A simple method for detection of human factor IX inhibitor using ELISA. Scand J Clin Lab Invest 1997; 57: 683-8.
19. Pengo V, Tripodi A, Reber G et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737-40.
20. Lindgren A, Wadenvik H, Tengborn L. Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A. Haemophilia 2002; 8: 644-8.
21. Barrow RT, Healey JF, Jacquemin MG, Saint-Remy JM, Lollar P. Antigenicity of putative phospholipid membrane-binding residues in factor VIII. Blood 2001; 97: 169-74.
22. Shetty S, Bhave M, Ghosh K. Acquired hemophilia A: diagnosis, aetiology, clinical spectrum and treatment options. Autoimmun Rev 2011; 6: 311-6.
23. Triplett DA, Asherson RA. Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). Am J Hematol 2000; 65: 154-9.
24. Arnout J. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thromb Haemost 2001; 86: 83-91.
25. Ballard HS, Nyamuswa G. Life-threatening haemorrhage in a patient with rheumatoid arthritis and a lupus anticoagulant coexisting with acquired autoantibodies against factor VIII. Br J Rheumatol 1993; 32: 515-7.
26. Akahoshi M, Aizawa K, Nagano S et al. Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature review. Mod Rheumatol 2008; 18: 511-5.
27. Triplett DA. Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors. Am J Hematol 1997; 56: 195-6.
28. Blanco AN, Lazzari MA. Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors in hemophilia. Am J Hematol 1998; 58: 248.
29. Pauzner R, Greinacher A, Selleng K, Althaus K, Shenkman B, Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost 2009; 7: 1070-4.
30. Castro AR, Morrill WE, Shaw WA et al. Use of synthetic cardiolipin and lecithin in the antigen used by the venereal disease research laboratory test for serodiagnosis of syphilis. Clin Diagn Lab Immunol 2000; 7: 658-61.
31. Dembitzer FR, Suarez Y, Aledort LM, Peerschke EI. Screening coagulation testing using the APTT: which reagent to choose? Am J Hematol 2010; 85: 726.
32. De ME, Wahl D, Perret-Guillaume C et al. A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants. Thromb Haemost 1998; 79: 237-8.